The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan

OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Laryngoscope
Auteurs principaux: Fujieda, Shigeharu, Matsune, Shoji, Takeno, Sachio, Asako, Mikiya, Takeuchi, Makiko, Fujita, Hiroyuki, Takahashi, Yoshinori, Amin, Nikhil, Deniz, Yamo, Rowe, Paul, Mannent, Leda
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2020
Sujets:
Allergy, Rhinology, and Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://ncbi.nlm.nih.gov/pubmed/33226139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.29230
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires